Other
Gene Expression
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Gene Expression is an early-stage landscape with 0 programs across 1 company. The most active players are Solvay Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
24
clinical trials
Completed16 · 67%
Terminated3 · 13%
Recruiting2 · 8%
Withdrawn2 · 8%
Unknown status1 · 4%
Clinical Trials
Trial Activity
24 trials
[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients
Recruiting·FFirst Affiliated Hospital of Chongqing Medical University·Phase 1·NCT06419361·30 enrolled
The Impact of Sage Extract on GTS B and D Gene Expression in S. Mutans
Completed·—·N/A·NCT06703554·24 enrolled
Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00324389·2 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)